Polymer particles

US10144793B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10144793-B2
Application numberUS-201815910976-A
CountryUS
Kind codeB2
Filing dateMar 2, 2018
Priority dateSep 19, 2013
Publication dateDec 4, 2018
Grant dateDec 4, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

First claim

Opening claim text (preview).

We claim: 1. A polymer particle comprising: a reaction product of a prepolymer solution including at least one monomer including at least one functional group; and at least one crosslinker selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate, wherein a, b, c, d, e, and f are each independently 1-20; wherein the polymer particle is susceptible to degradation through hydrolysis or enzymatic action. 2. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 40 μm and about 1,200 μm. 3. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 75 μm and about 1,200 μm. 4. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 50 μm and about 1,500 μm. 5. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 100 μm and about 1,000 μm. 6. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 40 μm and about 60 μm. 7. The polymer particle of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide. 8. The polymer particle of claim 1 , wherein the at least one monomer includes an ionizable functional group. 9. The polymer particle of claim 8 , wherein the ionizable functional group is basic or acidic. 10. The polymer particle of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 11. The polymer particle of claim 1 , wherein the polymer particle is biodegradable. 12. The polymer particle of claim 1 , wherein the polymer particle is substantially degraded within about 1 months of implantation. 13. The polymer particle of claim 1 , wherein the at least one monomer is dimethylacrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 14. The polymer particle of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate. 15. The polymer particle of claim 1 having a fraction of circularity of greater than about 0.8. 16. The polymer particle of claim 1 having a fraction of circularity of greater than about 0.9. 17. The polymer particle of claim 1 , wherein the degradation is in less than about 1 month. 18. The polymer particle of claim 1 , wherein the degradation is in less than about 6 months. 19. The polymer particle of claim 1 , further including a dye. 20. The polymer particle of claim 19 , wherein the dye is reactive blue 21, reactive orange 78, reactive yellow 15, reactive blue No. 19, reactive blue No. 4, C.I. reactive red 11, C.I. reactive yellow 86, C.I. reactive blue 163, C.I. reactive red 180, C.I. reactive black 5, C.I. reactive orange 78, C.I. reactive yellow 15, C.I. reactive blue No. 19, C.I. reactive blue 21, or a combination thereof.

Assignees

Inventors

Classifications

  • substituted imides comprising other heteroatoms · CPC title

  • Homopolymers or copolymers of acrylamide or methacrylamide · CPC title

  • Carboxylic acid amides · CPC title

  • Nitrogen-containing compounds {(C08K5/0091 takes precedence)} · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10144793B2 cover?
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
Who is the assignee on this patent?
Terumo Corp
What technology area does this patent fall under?
Primary CPC classification C08J3/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).